SCHEMBL7350858

SCHEMBL7350858

CCOC(=O)C1(NC=O)Cc2ccccc2NC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.50
HSD17B10 Q99714 2/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38
ADCY8 P40145 1/20 0.38
OPRM1 P35372 3/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
SLC22A1 O15245 1/20 0.36
SLC6A4 P31645 1/20 0.36
ADRA1A P35348 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
KCNH2 Q12809 1/20 0.36
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29715369 0.84 BRD4 (0.51) BRD4HSD17B10KDM4ELMNAMAPK1
SCHEMBL23099736 0.84 BRD4 (0.51) BRD4HSD17B10KDM4ELMNAMAPK1
SCHEMBL4063807 0.84 BRD4 (0.51) BRD4HSD17B10KDM4ELMNAMAPK1
SCHEMBL653420 0.77 BRD4 (0.60) BRD4KDM4ELMNAADCY8OPRM1
SCHEMBL13744265 0.76 BRD4 (0.55) BRD4HSD17B10KDM4ELMNAADCY8
SCHEMBL7342774 0.70 OPRM1 (0.36) KDM4ELMNAOPRM1SLC22A1SLC6A4
SCHEMBL5806109 0.70 SMN1; SMN2 (0.37) BRD4HSD17B10MAPK1IDO1TDO2
SCHEMBL30576474 0.70 MAPT (0.41) BRD4LMNATSHRSMN1; SMN2ALDH1A1
SCHEMBL25329234 0.70 MAPT (0.41) BRD4LMNATSHRSMN1; SMN2ALDH1A1
SCHEMBL23092762 0.69 BRD4 (0.44) BRD4LMNAOPRM1SLC22A1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed